In vivo dendritic cell reprogramming for cancer immunotherapy | Science




Immunotherapy can lead to long-term survival for some cancer patients, yet generalized success has been hampered by insufficient antigen presentation and exclusion of immunogenic cells from the tumor microenvironment. Here, we developed an approach to …



Source link

About The Author

Scroll to Top